FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Medical Devices

Quality System Issues at Argentinas Terragene

FDA warns Argentinas Terragene S.A. about Quality System violations in its manufacturing of Biological and Chemical Sterilization Process Indicator Sy...

latest-news-card-1
Human Drugs

Turkish Drug Company Has CGMP Issues: FDA

FDA warns Avcilar/Istanbul, Turkey-based Sudesan Temizlik Urunleri Ve Ambalaj Sanaryi Ticaret Anomin Sirketi about CGMP violations in its production o...

latest-news-card-1
Human Drugs

Clinical Investigation Didnt Follow Plan: FDA

FDA warns Anish Shah, doing business as Siyan Clinical Research in Santa Rosa, CA, about not following the investigational plan for a clinical investi...

latest-news-card-1
Human Drugs

Update on FDA Real-World Evidence Activities

FDA commissioner Robert Califf says the agency recently published three additional guidances to help advance the use of real-world data and real-world...

latest-news-card-1
Human Drugs

Real-World Data Registries Guidance

FDA publishes a guidance on assessing registries to support drug and biologic regulatory decision-making as part of its real-world evidence program.

latest-news-card-1
Medical Devices

ResMed Updates Labeling for Masks with Magnets

FDA says ResMed has issued updated instructions for its masks with magnets to inform users about potential magnetic interference when magnets are near...

latest-news-card-1
Human Drugs

Rare Disease Drug Development Guidance

FDA publishes a guidance to assist sponsors in conducting efficient and successful drug development programs to treat rare diseases.

latest-news-card-1
Human Drugs

Drug Development Master Protocol Guidance

FDA publishes a draft guidance making recommendations on the design and analysis of drug development trials conducted under a master protocol.

latest-news-card-1
Human Drugs

Updated Labeling for Promethazine HCl

FDA requires updated labeling for promethazine HCl injection to recommend administration through deep intramuscular rather than intravenous administra...

latest-news-card-1
Biologics

Cell/Gene Product Potency Assurance

FDA publishes a draft guidance on developing a science- and risk-based strategy to help assure the potency of a human cellular therapy or gene therapy...